Siegfried opens new global R&D Center for Drug Substances in Evionnaz

New facility to drive development excellence and further growth

21-Nov-2024 - Siegfried inaugurated its new global Research and Development (R&D) Center for Drug Substances at its site in Evionnaz, Switzerland. The 4,500m2 R&D Center houses advanced chemical and analytical facilities, state-of-the-art laboratories, and cutting-edge technologies such as flow chemistry, ...

Evotec announces sale of API manufacturing facility to Monacum Partners

New ownership committed to maintaining and growing the business

06-Nov-2024 - Evotec SE has announced the sale of its chemical API manufacturing site, Evotec DS GmbH, located in Halle/Westphalia, to Monacum Partners GmbH - a Munich based Private Equity firm. This transaction forms part of Evotec’s “Priority Reset” initiative launched in April 2024, which aims to foster ...

AI designs new drugs based on protein structures

“It’s a real breakthrough for drug discovery”: Process ensures right from the start that the molecules can be chemically synthesised

25-Apr-2024 - A new computer process developed by chemists at ETH Zurich makes it possible to generate active pharmaceutical ingredients quickly and easily based on a protein’s three-​dimensional surface. The new process could revolutionise drug research. “It’s a real breakthrough for drug discovery,” says ...

A new path to active ingredient diversity

26-Mar-2024 - Many important drugs, such as antibiotics and cancer drugs, are derived from natural substances from bacteria. The bacterial enzymes that produce these active ingredients are considered ideal tools for synthetic biology due to their modular design. By researching protein evolution, a team led by ...

Start-up dedicated to developing new antibiotics

Smartbax nominated for Falling Walls award

06-Nov-2023 - It all began with basic research: While conducting laboratory experiments, a team at the Technical University of Munich (TUM) came across an active agent against multidrug-resistant bacteria with a fundamental difference to antibiotics developed to date. The researchers have since established a ...

SUANFARMA announces a collaboration with Reyoung Pharmaceutical

The main objective of the collaboration is to introduce generic pharmaceutical ingredients to the market for the treatment of infectious diseases

19-Oct-2023 - SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. Reyoung´s decades of experience as an exporter of products worldwide are perfectly aligned with SUANFARMA, which has been ...

Novel antibiotics in the fight against antimicrobial resistance

SANTERO announces a €8 million Series A funding round led by Newton Biocapital

12-Jun-2023 - Newton Biocapital (NBC), a venture capital firm focused on investing and growing early-stage life sciences companies in Europe and Japan targeting chronic health conditions, has announced the closing of a successful €8 million Series A financing round for Santero. SANTERO, a spin-off company of ...

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 - The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-neutral ...

More Sustainability with Mechanochemistry

Research project will develop new environmentally friendly methods for manufacturing active pharmaceutical ingredients using mechanochemistry as a disruptive technology

29-Sep-2022 - Flour, coffee or spices: Many people know the principle of a mill from the kitchen. But special mills are also used for research purposes in the laboratories of the Max-Planck-Institut für Kohlenforschung. The scientists are convinced that mechanochemistry can make the chemical industry more ...

Siegfried begins construction of new large-scale production plant in Minden (DE)

Total investment of up to CHF 100 million

26-Aug-2022 - Siegfried broke ground and celebrated the start of the construction of its new large-scale production plant in Minden, Germany. The planned production plant, for which Siegfried will invest up to CHF 100 million, is the largest building project in the company's history. The new facility, which is ...